Community pharmacists' preparedness for substituting biologics and dispensing biosimilars - Lessons learned from a multinational survey.
Automatic substitution
Biologicals
Biosimilars
Community pharmacy
Interchangeability
Pharmacy
Journal
Exploratory research in clinical and social pharmacy
ISSN: 2667-2766
Titre abrégé: Explor Res Clin Soc Pharm
Pays: United States
ID NLM: 9918266300706676
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
25
06
2021
revised:
11
10
2021
accepted:
19
10
2021
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
Interchangeability between biological medicines and biosimilars, and subsequent substitution by pharmacists represent an important opportunity for costs savings for health care systems. Because biological medicines are complex products, the expert role of the pharmacist to inform patients and support physicians is indispensable. However, regulations on substitution of biosimilars differ around the globe, such that a substitution that is allowed in one country may be forbidden in another. Overall, pharmacists' knowledge of biosimilar medicines is incomplete and hesitancy to engage in substitutions is perceptible. As counter-balancing remedy, continued education about biosimilars is needed among practicing community pharmacists.
Identifiants
pubmed: 35479848
doi: 10.1016/j.rcsop.2021.100084
pii: S2667-2766(21)00084-6
pmc: PMC9032461
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100084Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
BioDrugs. 2021 Jan;35(1):75-87
pubmed: 33306186
Pharmaceuticals (Basel). 2020 Oct 21;13(10):
pubmed: 33096709
Int J Gen Med. 2020 Nov 11;13:1075-1082
pubmed: 33204142
MAbs. 2017 Feb/Mar;9(2):383-390
pubmed: 27929743
Autoimmun Rev. 2014 Jul;13(7):751-5
pubmed: 24657898
Regul Toxicol Pharmacol. 2017 Aug;88:252-261
pubmed: 28666961
Cancer Discov. 2015 May;5(5):460
pubmed: 25790983
Expert Rev Anticancer Ther. 2015 Mar;15(3):331-8
pubmed: 25539719
Am J Pharm Educ. 2013 Oct 14;77(8):162
pubmed: 24159203
Eur J Clin Pharmacol. 2019 Jan;75(1):1-11
pubmed: 30187103
Biol Ther. 2011 Dec 16;1:5
pubmed: 24392295
Eur J Intern Med. 2016 Nov;35:e31-e33
pubmed: 27461988
Biologicals. 2020 May;65:1-9
pubmed: 32224101
Biol Ther. 2013;3:35-43
pubmed: 24392303
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Nov;63(11):1365-1372
pubmed: 33034693